Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 07

330P - Does hepatitis C independently increase the risk of colorectal adenoma?

Date

10 Sep 2022

Session

Poster session 07

Topics

Population Risk Factor;  Clinical Research;  Primary Prevention;  Secondary Prevention/Screening

Tumour Site

Colon and Rectal Cancer

Presenters

Maya Gogtay

Citation

Annals of Oncology (2022) 33 (suppl_7): S136-S196. 10.1016/annonc/annonc1048

Authors

M. Gogtay1, Y. Singh1, A. Bullappa2, A. Yekula1, G. Abraham1

Author affiliations

  • 1 Internal Medicine, Saint Vincent Hospital, 01608 - Worcester/US
  • 2 Community Medicine, S.S.Institute of medical sciences, 577003 - Davangere/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 330P

Background

Hepatitis C virus (HCV) infection has been associated with extrahepatic malignancies, one such is colorectal carcinoma (CRC). Majority of CRC arise from adenomatous polyps, it is not known if HCV influences the growth of these precancerous lesions. This study evaluates the prevalence of colorectal adenomas in HCV patients and if HCV is an independent risk factor for the detection of colorectal adenomas.

Methods

This case-control study included patients who underwent colonoscopy. Patients were divided into cases (HCV) and controls (non-HCV). Patients with no biopsy reports, hepatitis B, and inflammatory bowel disease were excluded. Colonoscopy findings were stratified on the biopsy results i.e., hyperplastic, adenomatous, CRC or normal mucosa. Continuous variables were analyzed using Mann Whitney U test and categorical variables using Chi-square with p<0.05 considered statistically significant. After 1:1 propensity score matching (PSM), a matched cohort was generated. A multivariate regression analysis to compute an odds ratio for colorectal adenoma detection rate was done.

Results

415 patients were screened, of which 109 HCV patients and 97 controls were included. Descriptive analysis showed that age, BMI, aspirin use , smoking, alcohol use and adenoma detection were significantly different between both groups (p<0.05). After propensity matching, multivariate regression analysis showed patients with HCV had odds ratio (OR) = 2.06 (p = 0.03), and aspirin use had OR = 0.38 (p = 0.01) in having colorectal adenoma. Table: 330P

Multivariate logistic regression for colorectal adenoma

Variables p value OR Upper limit CI Lower limit of CI
Median age 0.0295* 1.043 1.034 2.125
HCV 0.0314* 2.152 1.125 3.810
Familal CRC 0.220 1.984 0.665 5.922
Aspirin use 0.0116* 0.387 0.253 0.89
Smoking 0.499 1.229 0.677 2.231
Alcohol 0.293 1.527 0.694 3.359
Female gender 0.869 1.050 0.586 1.882
Diabetes mellitus 0.529 1.244 0.630 2.459
HIV co-infection 0.895 1.148 0.150 8.806

Conclusions

Our study shows a significantly higher rate of adenomas in chronic HCV patients. On multivariate analysis, HCV infection was found to be an independent risk factor for colorectal adenoma. Current guidelines do not recommend earlier CRC screening. Prospective studies would be required to assess if treatment of HCV leads to lower adenomas.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.